AdvanceBio Peptide Plus Series

Based on Agilent superficially porous Poroshell technology, AdvanceBio Peptide Plus columns feature a hybrid endcapped C-18 stationary phase on a 100 Å pore size, 2.7 μm particle modified to have a charged surface. With UHPLC performance at HPLC pressures, you can use AdvanceBio Peptide Plus columns across all of your LCs.

Agilent AdvanceBio Peptide Plus columns offer the selectivity you need with excellent reproducibility.

• Alternate selectivity that often improves separation of critical components that traditional C18 columns cannot resolve
• Excellent performance with alternate selectivity from the charged surface, improving resolution for peptides with post-translational modifications and degradation products
• FA compatibility and multiple dimensions, so you can choose a single column for early development through QA/QC, and across multiple system platforms
• High loadability, so you can analyze very minor components in samples by injecting a large amount of sample
• Quality assurance, as every column is batch tested with the Agilent peptide mapping standard mix

Agilent AdvanceBio Peptide Plus Brochure